These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6431075)

  • 21. A randomized two way cross over study for comparison of absorption of vitamin D3 buccal spray and soft gelatin capsule formulation in healthy subjects and in patients with intestinal malabsorption.
    Satia MC; Mukim AG; Tibrewala KD; Bhavsar MS
    Nutr J; 2015 Oct; 14():114. PubMed ID: 26514332
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of nitroglycerin and its metabolites after administration of sustained-release tablets.
    Kwon HR; Green P; Curry SH
    Biopharm Drug Dispos; 1992 Mar; 13(2):141-52. PubMed ID: 1550909
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Intranasal administration of nitroglycerin solution and nitroglycerin spray during general anesthesia].
    Iwasaka H; Kunisaki Y; Yamamoto H; Kitano T; Kinoshita R; Taniguchi K; Honda N
    Masui; 1993 Oct; 42(10):1423-8. PubMed ID: 8230691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nitroglycerin lingual spray: clinical efficacy and dose-response relation.
    Parker JO; Vankoughnett KA; Farrell B
    Am J Cardiol; 1986 Jan; 57(1):1-5. PubMed ID: 3079939
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of Formulation on the Pharmacokinetics of Dutasteride: Results from Two Phase I Studies.
    Fossler M; Zhu J; Roehrborn C; McAleese P; Manyak M
    Clin Drug Investig; 2016 Sep; 36(9):763-767. PubMed ID: 27356530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased exercise tolerance after nitroglycerin oral spray: a new and effective therapeutic modality in angina pectoris.
    Kimchi A; Lee G; Amsterdam E; Fujii K; Krieg P; Mason DT
    Circulation; 1983 Jan; 67(1):124-7. PubMed ID: 6401172
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biopharmaceutical evaluation of methylcellulose as an excipient for nitroglycerin tablets.
    Shibuya F; Kuramoto K; Koizumi H; Uehara N; Nakagawa F; Tamura Z; Murayama M; Kawakubo K; Kawahara T; Ohshiro M
    J Pharmacobiodyn; 1985 May; 8(5):352-6. PubMed ID: 3930694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized crossover evaluation of antianginal efficacy and safety of nitrolingual-spray and nitroglycerin tablet form in coronary artery disease patients.
    Chien KL; Sung FC; Chao CL; Su TC; Chen MF; Lee YT
    Cardiology; 2000; 93(3):137-41. PubMed ID: 10965083
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Digital plethysmography for assessing erythrityl tetranitrate bioavailability.
    Hannemann RE; Erb RJ; Stoltman WP; Bronson EC; Williams EJ; Long RA; Hull JH; Starbuck RR
    Clin Pharmacol Ther; 1981 Jan; 29(1):35-9. PubMed ID: 7006882
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incomplete and delayed bioavailability of sublingual nitroglycerin.
    Noonan PK; Benet LZ
    Am J Cardiol; 1985 Jan; 55(1):184-7. PubMed ID: 3917598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bioavailability and patient acceptance of cyclosporine soft gelatin capsules in renal allograft recipients.
    Min DI; Hwang GC; Bergstrom S; Madras PN; Shaffer D; Sahyoun AI; Monaco AP
    Ann Pharmacother; 1992 Feb; 26(2):175-9. PubMed ID: 1554925
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Some factors influencing the bioavailability of zinc in oral pharmaceutical dosage forms].
    Neve J; Hanocq M; Peretz A; Abi Khalil F; Pelen F
    J Pharm Belg; 1993; 48(1):5-11. PubMed ID: 8483101
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pharmacodynamic equivalence and clinical trial of a new fluorocarbon-free glycerol trinitrate pump spray with low ethanol content in comparison to a fluorocarbon-containing reference spray and a fluorocarbon-free pump spray with high ethanol content].
    Erb K; de Mey C; Zimmermann T; Mutschler H; Roll S; Belz GG
    Arzneimittelforschung; 1994 Apr; 44(4):478-82. PubMed ID: 8011000
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pharmacodynamics of nitroglycerin for sublingual medication in ischemic heart disease].
    Savvateev KL; Metelitsa VI
    Kardiologiia; 1982 Jan; 22(1):65-70. PubMed ID: 6801369
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myo-inositol in a new pharmaceutical form: a step forward to a broader clinical use.
    Carlomagno G; De Grazia S; Unfer V; Manna F
    Expert Opin Drug Deliv; 2012 Mar; 9(3):267-71. PubMed ID: 22339497
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of venodilatory effects of nitroglycerin spray and tablets in healthy volunteers.
    Fanelli C; Zelis R; Gascho JA
    Am J Cardiol; 1989 Mar; 63(9):637-9. PubMed ID: 2493189
    [No Abstract]   [Full Text] [Related]  

  • 37. [Prolonged hemodynamic effects of a nitroglycerin microcapsule preparation administed orally (author's transl)].
    Guéret P; Rigaud M; Bardet J; Bourdarias JP
    Nouv Presse Med; 1980 Sep; 9(34 Suppl):2451-4. PubMed ID: 6775297
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Accuracy and precision of metered doses of nitroglycerin lingual spray.
    Price JW; Price JR
    Am J Health Syst Pharm; 2008 Aug; 65(16):1556-9. PubMed ID: 18693212
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nitroglycerin concentration in plasma: comparison between transdermal therapeutic system and ointment.
    Chu LC; Gale RM; Schmitt LG; Shaw JE
    Angiology; 1984 Sep; 35(9):545-52. PubMed ID: 6435484
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The assessment of the intrasubject variability in digoxin absorption in man from two oral dosage forms.
    Yacobi A; Stoll RG; Chao GC; Schwartz RA; Weidler DJ; Ayers JW; Sakmar E; Hallmark M; Wagner JG
    J Clin Pharmacol; 1981 Jul; 21(7):301-10. PubMed ID: 7263929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.